Enhanced topical delivery and ex vivo anti-inflammatory activity from a betamethasone dipropionate formulation containing fish oil
- 31 July 2009
- journal article
- research article
- Published by Springer Nature in Inflammation Research
- Vol. 59 (1) , 23-30
Abstract
To probe ex vivo the influence of fish oil (FO) on the topical delivery and anti-inflammatory properties of betamethasone dipropionate (BD). Freshly excised porcine ear skin. Ointment formulations containing BD + salicylic acid (SA), BD + SA + FO, or base as control, applied to the skin mounted in Franz cells. Comparative depth profiling; skin probed by immunohistochemistry for cyclooxygenase-2 (COX-2) and by ELISA for prostaglandin E2 (PGE2). More BD was obtained in the first 30 layers and the remaining epidermis with BD + SA. However, more penetrants were recovered from the remaining skin treated with BD + SA + FO. Although BD + SA reduced COX-2 expression within the epidermis, greater reduction was observed with BD + SA + FO as indicated by reduced COX-2 expression. FO alone had a comparable effect on the expression of COX-2. Modulation of PGE2 production also supported the anti-inflammatory properties of fish oil, reducing PGE2 levels by an amount comparable to the reduction by BD. Combining FO and BD, however, did not provide the anticipated potentiation effect. Fish oil enhanced the delivery of BD and SA across skin. Addition of fish oil also enhanced the anti-inflammatory activity of BD, attributed to increased amounts of BD present in the skin and/or the intrinsic anti-inflammatory activity of fish oil.Keywords
This publication has 30 references indexed in Scilit:
- Lipoxins and new lipid mediators in the resolution of inflammationCurrent Opinion in Pharmacology, 2006
- COX-2 in Inflammation and ResolutionMolecular Interventions, 2006
- Understanding omega-3'sAmerican Heart Journal, 2006
- Clinical studies of a new vehicle formulation for topical corticosteroids in the treatment of psoriasisJournal of the American Academy of Dermatology, 2005
- 15-lipoxygenase metabolites of -linolenic acid/eicosapentaenoic acid suppress growth and arachidonic acid metabolism in human prostatic adenocarcinoma cells: Possible implications of dietary fatty acidsProstaglandins, Leukotrienes and Essential Fatty Acids, 2005
- Inflammatory Mediators in Normal, Sensitive and Diseased Skin Types: Investigative ReportActa Dermato-Venereologica, 2000
- Growth inhibitory effect of eicosapentaenoic acid on cultured human epidermal keratinocytesJournal of Dermatological Science, 1993
- Long-Term Administration of Highly Purified Eicosapentaenoic Acid Provides Improvement of PsoriasisDermatology, 1991
- Topical corticosteroid compounding: Effects on physicochemical stability and skin penetration rateJournal of the American Academy of Dermatology, 1989
- Metabolism of linoleic acid and other essential fatty acids in the epidermis of the ratBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1985